Physician

Amy M. Toscano-Zukor, D.O.

According to 2025 Medicare claims, Amy Toscano-Zukor, D.O. (NPI: 1821269341) practices endocrinology in the Newark, NJ market, with the plurality of this provider's patient population coming from Union, NJ. This provider's primary affiliated billing organization is SUMMIT MEDICAL GROUP PA (NPI: 1942254347; TIN: 223487984) and primary practice location at 07974-1218. Toscano-Zukor is affiliated with the Summit Health ACO (ACO ID: A5049), participating under the MSSP model.

Toscano-Zukor's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 762 traditional Medicare patients, billed 5,363 HCPCS/CPT codes, and received $168,750 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 4,992 prescription claims across 666 beneficiaries totaling $1,422,924 in drug costs, led by Mounjaro (Tirzepatide). DME data shows 663 claims. No Open Payments records. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $435,523 to $1,422,924. For DME billing, reported payments rose steadily, from $1,603 to $192,091.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	621	5,451	$155,532
2016	779	7,208	$175,302
2017	956	7,267	$183,744
2018	885	6,776	$179,703
2019	975	6,741	$176,053
2020	925	7,786	$187,613
2021	915	7,499	$216,141
2022	736	7,481	$185,316
2023	940	7,874	$208,686
2024	762	5,363	$168,750

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	376	2,143	$435,523
2016	408	2,725	$591,267
2017	455	3,128	$774,236
2018	541	3,655	$1,029,493
2019	573	4,013	$1,146,418
2020	602	4,249	$1,176,669
2021	686	4,938	$1,504,643
2022	684	5,338	$1,748,024
2023	687	5,314	$1,995,348
2024	666	4,992	$1,422,924

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	207	512	$10,711
2016	227	453	$10,000
2017	204	451	$7,864
2018	185	486	$13,968
2019	178	488	$30,373
2020	174	535	$44,666
2021	193	627	$55,725
2022	221	813	$90,742
2023	230	991	$151,383
2024	181	663	$186,783

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	502	746	$105
77080	Dxa bone density measurement of hip, pelvis, spine	291	291	$44
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	468	627	$14
80053	Blood test, comprehensive group of blood chemicals	248	261	$10
36415	Insertion of needle into vein for collection of blood sample	288	328	$9

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Mounjaro	Tirzepatide	170	8,628	$304,002
Ozempic	Semaglutide	157	8,662	$265,039
Trulicity	Dulaglutide	62	3,290	$104,504
Jardiance	Empagliflozin	75	4,840	$88,589
Teriparatide	Teriparatide	19	654	$55,889

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4239	Supply allowance for non-adjunctive, non-implanted continuous glucose monitor (cgm), includes all supplies and accessories, 1 month supply = 1 unit of service	N	75	366	$164,279
E0784	External ambulatory infusion pump, insulin	Y	N/R	29	$9,301
A4224	Supplies for maintenance of insulin infusion catheter, per week	N	N/R	25	$5,766
A4253	Blood glucose test or reagent strips for home blood glucose monitor, per 50 strips	N	63	148	$2,620
E2103	Non-adjunctive, non-implanted continuous glucose monitor or receiver	N	13	13	$2,552

Open Payments Summary

No connected Open Payments records were found for this physician in General Payments, Research Payments, or Ownership / Investment Interests.

Explore More Providers

FAQ

What Medicare data is available for Amy M. Toscano-Zukor, D.O.?

Tedicare shows public-source Medicare data for Amy M. Toscano-Zukor, D.O. (NPI 1821269341), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Amy M. Toscano-Zukor, D.O. have ACO affiliation data?

Amy M. Toscano-Zukor, D.O. is shown with ACO affiliation data for Summit Health ACO (MSSP, ACO ID A5049).

What billing organization is linked to Amy M. Toscano-Zukor, D.O.?

Amy M. Toscano-Zukor, D.O. is linked to SUMMIT MEDICAL GROUP PA (billing NPI 1942254347) in the available physician profile data.

Does Amy M. Toscano-Zukor, D.O. have Open Payments data?

No connected Open Payments records are shown for this physician in the available General Payments, Research Payments, or Ownership / Investment Interests data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.